Because the world continues to hunt options in response to the coronavirus pandemic, Beckman Coulter Life Sciences pronounces it’s the first United States distributor of the Genedrive® 96 SARS-CoV-2 package. The settlement with the near-patient molecular diagnostics firm, genedrive plc (LSE: GDR), is for distribution within the US and all through Europe.
The Genedrive® 96 SARS-CoV-2 package is an easy, one-step RT-PCR check to detect SARS-CoV-2 RNA. It presents lyophilized reagents that allow product stability and permit for ambient transport and storage. The simple to arrange assay can streamline laboratory workflows, improve total throughput, and reduce potential errors for assay arrange. The Genedrive® 96 SARS-CoV-2 package has acquired the CE-IVD mark and is at the moment underneath FDA evaluation for Emergency Use Authorization (EUA).
Whilst vaccines are being administered there’s nonetheless a essential must proceed COVID-19 testing. This collaboration offers a turnkey resolution for specialised laboratories trying to set up new or expanded check capability with consumables and labor value discount. The flexibility to streamline the workflow by concurrently making ready pattern extraction and downstream assay arrange is a essential step ahead in advancing COVID testing workflows, growing throughput and decreasing consumables utilization.”
Greg Milosevich, President, Beckman Coulter Life Sciences
To study extra about Genedrive® 96 SARS-CoV-2 Kit please go to our product overview web page.